In addition to CSF hormones quantification, HPA axis activity in subjects with AD was evaluated through a stimulation test with intravenous administration of 100 μg of recombinant human CRH (rhCRH) in parallel to the measurement of plasma cortisol at 15, 30, 60, and 120 minutes. The gene discussed is CRH; the disease is Alzheimer disease.